Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation
Matthew H.G. Katz, Gauri R. Varadhachary, Jason B. Fleming, Robert A. Wolff, Jeffrey E. Lee, Peter W.T. Pisters, Jean Nicolas Vauthey, Eddie K. Abdalla, Charlotte C. Sun, Huamin Wang, Christopher H. Crane, Jeffrey H. Lee, Eric P. Tamm, James L. Abbruzzese, Douglas B. Evans
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation'. Together they form a unique fingerprint.